U.S. flag

An official website of the United States government

NM_004360.5(CDH1):c.1703C>G (p.Thr568Arg) AND Hereditary diffuse gastric adenocarcinoma

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 19, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001326496.8

Allele description [Variation Report for NM_004360.5(CDH1):c.1703C>G (p.Thr568Arg)]

NM_004360.5(CDH1):c.1703C>G (p.Thr568Arg)

Gene:
CDH1:cadherin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q22.1
Genomic location:
Preferred name:
NM_004360.5(CDH1):c.1703C>G (p.Thr568Arg)
Other names:
NM_004360.5(CDH1):c.1703C>G; p.Thr568Arg
HGVS:
  • NC_000016.10:g.68819417C>G
  • NG_008021.1:g.87126C>G
  • NM_001317184.2:c.1520C>G
  • NM_001317185.2:c.155C>G
  • NM_001317186.2:c.-254-2584C>G
  • NM_004360.5:c.1703C>GMANE SELECT
  • NP_001304113.1:p.Thr507Arg
  • NP_001304114.1:p.Thr52Arg
  • NP_004351.1:p.Thr568Arg
  • LRG_301t1:c.1703C>G
  • LRG_301:g.87126C>G
  • NC_000016.9:g.68853320C>G
  • NM_004360.3:c.1703C>G
Protein change:
T507R
Links:
dbSNP: rs786202712
NCBI 1000 Genomes Browser:
rs786202712
Molecular consequence:
  • NM_001317186.2:c.-254-2584C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001317184.2:c.1520C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001317185.2:c.155C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004360.5:c.1703C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary diffuse gastric adenocarcinoma (HDGC)
Synonyms:
Hereditary diffuse gastric cancer
Identifiers:
MONDO: MONDO:0007648; MedGen: C1708349; Orphanet: 26106; OMIM: 137215

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001517528Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Sep 19, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer.

Karam R, Conner B, LaDuca H, McGoldrick K, Krempely K, Richardson ME, Zimmermann H, Gutierrez S, Reineke P, Hoang L, Allen K, Yussuf A, Farber-Katz S, Rana HQ, Culver S, Lee J, Nashed S, Toppmeyer D, Collins D, Haynes G, Pesaran T, Dolinsky JS, et al.

JAMA Netw Open. 2019 Oct 2;2(10):e1913900. doi: 10.1001/jamanetworkopen.2019.13900.

PubMed [citation]
PMID:
31642931
PMCID:
PMC6820040

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001517528.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 428619). This missense change has been observed in individual(s) with diffuse gastric cancer (PMID: 31642931). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 568 of the CDH1 protein (p.Thr568Arg).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024